When was Pfizer Aware that Lipitor Causes Diabetes in Women?

The number of Lipitor lawsuits is on the rise. In fact, there have been so many suits filed, that a motion has been submitted to consolidate them in only one federal court. When these lawsuits are eventually brought to trial, one of the biggest questions pharmaceutical giant Pfizer will have to answer is “when did you know that lipitor causes diabetes in women?”

This medication officially changed its label to include a warning about the increased dangers in 2012. The new warning advised patients there could be increased fasting serum glucose levels, but never warned about the dangers of contracting diabetes directly. Many litigants claim that this was not an adequate warning. They also allege that the company should have known about the increased diabetes risk much earlier than that, perhaps even before they released the drug in 1997.

The Huffington Post first reported on a study performed on the increased risk of diabetes among Lipitor patients in 2011. In doing so, they cite statistics from a research project at the University of California at San Francisco. This study reported that those who took Lipitor were at an increased risk for developing diabetes, particularly if they already had some of the risk factors for that disease.

This wasn’t the first time Lipitor had been linked to other health problems in patients. In 2006, a series of lawsuits was filed against Pfizer, alleging that this medication caused muscle and nerve damage and affected patients’ memories as well. These issues tended to affect men and women equally, and it has not yet been determined why women who take Lipitor seem to be at an increased risk of developing diabetes.

Patients who have contracted Type 2 diabetes after taking Lipitor could be entitled to recoup damages in a court of law. If you or a loved one fit into this category, contact us to find out if relief can be granted in your situation.